Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Instrumentarium Corp.

This article was originally published in The Gray Sheet

Executive Summary

Helsinki, Finland-based company reaches a basic agreement with Swedish firm Gambro AB under which Instrumentarium will acquire Gambro's anaesthesia and intensive care business. The business being acquired is comprised of the Gambro Engstrom AB, Engstrom Elektromedizin GmbH, Soxil SpA, and Engstrom MIE Ltd. divisions, based in Sweden, Germany, Italy, and the U.K., respectively. The four businesses had combined 1993 sales of approximately $58 mil., according to Instrumentarium. Instrumentarium says the acquisition will "particularly strengthen" its Datex division in the areas of anaesthesia and critical care equipment, where there is "a strong trend towards integration of patient monitoring, anaesthesia delivery and information management." Datex posted 1993 sales of about $100 mil

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002735

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel